Stamford, CT -- (SBWIRE) -- 01/22/2014 -- High Rising Stocks is engaged in providing the most up to date and useful information on the Best Penny Stocks that are poised to breakout. Our penny stock newsletter alerts the market with picks that Wall Street stock traders have ignored or haven’t found out about yet. Here are some of the most awesome penny stocks we came up with that the ‘underground penny stock experts’ are always bragging about in their penny stock newsletters. Have a look on today’s market movers: Advanced Micro Devices, Inc.(NYSE:AMD), Amarin Corporation plc (ADR)(NASDAQ:AMRN), Cell Therapeutics Inc(NASDAQ:CTIC), Provectus Pharmaceuticals, Inc.(OTCMKTS:PVCT)
Advanced Micro Devices, Inc.(NYSE:AMD) opened the session at $4.31, remained amid the day range of $4.13 - $4.34, and closed the session at $4.17. The stock showed a negative performance of -0.24% in previous trading session. The stock gained a volume of 59.71 million shares and the average volume of the stock remained 22.69 million shares. Advanced Micro Devices, Inc. operates as a semiconductor company worldwide. It operates in two segments, Computing Solutions and Graphics.
Will AMD Get Buyers Even After The Recent Rally? Find Out Here
Amarin Corporation plc (ADR)(NASDAQ:AMRN) traded with volume of 20.43 million shares in the prior session and the average volume of the stock remained 7.03 million shares. The 52 week range of the stock remained $1.36 - $8.97. The stock showed a negative movement of -23.79% and closed its session at $1.73. The market capitalization of the stock remained 298.67 million. Amarin Corporation plc (Amarin) is a late-stage biopharmaceutical -company with expertise in lipid science focused on the treatment of cardiovascular disease.
Why Should Investors Buy AMRN After the Recent Fall? Just Go Here and Find Out
Cell Therapeutics Inc(NASDAQ:CTIC) exchanged 24.19 million shares and the average volume remained 4.39 million shares. The stock escalated +15.66% and closed the session at $4.21. The beta of the stock remained 5.57 and the EPS of the stock remained -0.75. The shares outstanding of the stock remained 146.19 million. Cell Therapeutics, Inc. acquires, develops, and commercializes treatments for cancer.
For How Long CTIC will fight for Profitability? Read This Trend Analysis report
Provectus Pharmaceuticals, Inc.(OTCMKTS:PVCT) gained volume of 5.38 million shares, while the average volume remained 2.17 million shares. The stock advanced +36.11% and finished the session Tuesday at $3.99. The EPS of the stock remained -0.11. The one month of the stock was 504.24% and three month trend remained positive 504.24%.Provectus Pharmaceuticals, Inc., a development-stage pharmaceutical company, engages in developing pharmaceuticals for oncology and dermatology indications.
For How Long PVCT’s Gloss will Attract Investors ? Find out via this report
High Rising Stocks provides investors with the hottest penny stock alerts on a regular basis. It carries Hot Penny Stocks and Penny Stock Newsletter, we will send you alerts through our Free Penny Stock Newsletters with High Yielding alerts, market forecasting, stock tips and strategies, and offer you the tools to help you along the way with the goal of keeping you loyal to our service.
Carriage Consulting Group, High Rising Stocks, their Members, officers, directors, employees, affiliates, or any other related person(s) (collectively, “High Rising Stocks”) are not registered as a securities broker-dealer or an investment adviser either with the U.S. Securities and Exchange Commission (the “SEC”) or with any state securities regulatory authority. High Rising Stocks as defined are neither licensed nor qualified to provide investment advice and you are specifically and adamantly advised not to rely upon anything said/posted/communicated/implied or expressed by High Rising Stocks as defined.
Read full Disclaimer at: http://highrisingstocks.com/disclaimer/
Copyright © 2005-2014 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)